Determination of Total and Unbound Meropenem, Imipenem/Cilastatin, and Cefoperazone/Sulbactam in Human Plasma: Application for Therapeutic Drug Monitoring in Critically Ill Patients.

Abstract

BACKGROUND:

Critically ill patients show several pathophysiological alterations that can complicate antibiotic dosing. Hence, there is a strong rationale to individualize anti-infective dosing in these patients by using therapeutic drug monitoring (TDM). The current study aimed to develop and validate a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of total and unbound plasma concentrations of 3 commonly used antibiotics (meropenem, imipenem/cilastatin, and cefoperazone/sulbactam) in the treatment of infections in critically ill patients in China, which could be suitable for routine TDM in hospital laboratories.

METHODS:

The unbound drug was separated from the bound drug by ultrafiltration. Simple protein precipitation was used for sample preparation. Meropenem, imipenem/cilastatin, cefoperazone/sulbactam, and their corresponding internal standards were then resolved using the Waters CORTECS C18 column. All the compounds were detected using electrospray ionization in the positive/negative ion-switching mode.

RESULTS:

The calibration curves were linear for all compounds, with correlation coefficients (R) above 0.99 for total concentrations in human plasma and unbound concentrations in the plasma ultrafiltrate. For both total and unbound drugs, the relative errors and intra-assay/interassay relative standard deviations were below 15%. The limit of quantification was 0.05 mcg/mL for both total plasma concentrations and plasma ultrafiltrate concentrations of all compounds.

CONCLUSIONS:

The method was simple, rapid, and reliable and is currently being used to provide a TDM service to enhance the efficacious use of the 3 antibiotics.

• Authors: Zhi Rao, Zi-Long Dang, Bin Li, Lei Zhu, Hong-Yan Qin, Xin-An Wu, Yu-Hui Wei
• Journal: Therapeutic drug monitoring (Ther Drug Monit) Vol. 42 Issue 4 Pg. 578-587 (08 2020) ISSN: 1536-3694 [Electronic] United States
• PMID: 32049891 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Cilastatin
• Imipenem
• Cefoperazone
• Cilastatin, Imipenem Drug Combination
• Meropenem
• Sulbactam

Topics

• Cefoperazone (blood)
• Chromatography, High Pressure Liquid (methods)
• Cilastatin (blood)
• Cilastatin, Imipenem Drug Combination (blood)
• Critical Illness
• Drug Monitoring (methods)
• Humans
• Imipenem (blood)
• Meropenem (blood)
• Plasma (chemistry)
• Sulbactam (blood)
• Tandem Mass Spectrometry (methods)